Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis (IPF)

Explore clinical trials studying Idiopathic Pulmonary Fibrosis (IPF). Study availability and eligibility vary by location and protocol.

60 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis (IPF) trial results

Completed

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT01371305

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Kansas City, Kansas, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

NCT06588686

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • UAB Hospital, School of Medicine/Lung Health Center Birmingham, Alabama, United States
  • Keck Medicine of University of Southern California Los Angeles, California, United States
  • Paradigm Clinical Research Centers, Inc. Redding, California, United States
  • UC Davis Health System Sacramento, California, United States
View all 111 locations
View Trial Details
Active, Not Recruiting

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

NCT06636487

Conditions
Asthma Bronchiale, Bronchial Diseases, Bronchiectasis, +14 more
Locations
  • Copenhagen University Center, Amager Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Frederiksberg-Bispebjerg Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Hvidovre Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Herlev-Gentofte Gentofte Municipality, Greater Copenhagen, Denmark
View Trial Details
Active, Not Recruiting

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

NCT04598919

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Baylor University Medical Center (BUMC) Dallas, Texas, United States
View Trial Details

Related conditions